With the results obtained, we propose a model combining acute TLR7 treatment in young TC mice and spontaneous development in aged TC mice to better understand the mechanisms of subclinical microvascular impairment and reactive cardiac hypertrophy in SLE patients and improve their disease prevention or management. The gene discussed is TLR7; the disease is systemic lupus erythematosus.